Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Francine M. Foss, MD
Yale University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Aurora Presbyterian Hospital
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
- Ccop - Colorado Cancer Research Program
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - St. Luke'S Medical Center
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- St. Joseph Hospital
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- St. Mary'S Regional Cancer Center at St. Mary'S Hospital and Medical Center
Grand Junction, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado, United States
- St. Mary - Corwin Regional Medical Center
Pueblo, Colorado, United States
- North Suburban Medical Center
Thornton, Colorado, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- Tufts-Nemc Cancer Center
Boston, Massachusetts, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Cancer Institute of New Jersey at Umdnj - Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
- Case Comprehensive Cancer Center
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Nov 2005
- Primary completion
- 30 Apr 2008
- Completion
- 31 May 2011
- Last update posted
- 28 Jun 2023
- Registered enrollment
- 6
- Registry id
- NCT00057954
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.